Less Invasive CABG Facilitated By St. Jude Connector Devices, Firm Believes
This article was originally published in The Gray Sheet
Executive Summary
The long-term reliability of St. Jude Medical's sutureless anastomotic Connector devices could shift the coronary therapy market away from stents and toward bypass surgery (CABG), the company suggested during a May 1 investor conference.